top of page

Blog
White Paper Issue 17: Effectiveness of levamisole HCl and thymalfasin in two mouse models of ALS
Levamisole HCl and Zadaxin tested in two mouse models of ALS
Apr 6, 20223 min read
Â
Â
NDR White Paper Issue 11: Mechanisms of common pathologies in ALS
Despite the initial cause, all cases of ALS, familial or sporadic, follow a final common pathogenesis. The ability for the body to...
Jan 10, 20223 min read
Â
Â
NDR White Paper Issue 10: Genetics and ALS
In Ancient Egypt a person’s essence or soul was passed to their descendants, symbolized by Ka. Amyotrophic lateral sclerosis (ALS) has...
Jan 7, 20224 min read
Â
Â
White Paper Issue 9: Stress Response in ALS: Dr. Robert Naviaux
Research in our lab has led to a new understanding of the ancient biology that underlies the circle of injury and recovery. New medicines...
Jan 5, 20211 min read
Â
Â
NDR White Paper Issue 8: ALS and epigenetics
Nothing illustrates that change is the essence of life quite like the butterfly. How does this cloudless sulphur caterpillar, eating the...
Dec 26, 20204 min read
Â
Â
NDR White Paper Issue 7: Models of ALS
Cathleen Lutz (Jackson Laboratory) described ALS as a “complex disease and consists of a group of conditions unified by a common theme,...
Nov 20, 20207 min read
Â
Â
NDR White Paper Issue 6: Energy Metabolism
NDR is approaching ALS from multiple directions- in 2021 we have 17 active projects! What is fascinating is the emerging overlap between...
Nov 5, 20204 min read
Â
Â
NDR White Paper Issue 5: Activity of Thymosan
Immunonormalizing molecules thymopoietin and levamisole HCl Inflammation and regulation of inflammatory responses are necessary for life....
Aug 28, 20203 min read
Â
Â
NDR White Paper Issue 4: C9orf72
RAN Proteins The discovery of a repeat expansion1 in the C9orf72 gene is important because it is a model to explain central...
Aug 4, 20204 min read
Â
Â
NDR White Paper Issue 2: Treatments Are Lacking
NDR’s goals are simple, bring promising therapies to ALS patients and know which treatment is appropriate for a patient by evaluating...
May 7, 20204 min read
Â
Â
NDR White Paper Issue 1: Thymopoietin
Amyotrophic lateral sclerosis (ALS) is a motor neuron disease of animals and man with life-altering consequences. The defining pathology...
May 1, 20203 min read
Â
Â
bottom of page